
1. j infect dis. 2011 dec 1;204(11):1772-8. doi: 10.1093/infdis/jir629. epub 2011
oct 12.

human genetic variation associated plasmodium falciparum drug resistance.

paganotti gm(1), gallo bc, verra f, sirima bs, nebié i, diarra a, coluzzi m,
modiano d.

author information: 
(1)department public health infectious diseases, la sapienza university,
rome, italy. giacomo.paganotti@uniroma1.it

comment in
    j infect dis. 2013 feb 15;207(4):687-8.
    j infect dis. 2013 feb 15;207(4):688-9.

one approach investigate human genetic variation influences selection
of plasmodium falciparum drug resistance compare frequency resistant
infections among human populations differing genetic background and
living epidemiological context. complementary approach
consists comparing drug resistance among subjects differing genes involved
in drug metabolism. report, malariological surveys performed in
burkina faso, prevalence p. falciparum chloroquine-resistant
infections (pfcrt 76t and/or pfmdr1 86y alleles) differs among sympatric ethnic
groups, higher mossi rimaibé groups fulani group
(odds ratio [or], 2.24; 95% confidence interval [ci], 1.27-3.92; p = .007). the
association analysis revealed human cyp2c8*2 variant, known determine
a poor drug metabolizer phenotype, associated p. falciparum
chloroquine-resistant infections (or, 1.66; 95% ci, 1.13-2.43; p = .008). this
variant frequent mossi-rimaibé group (23.7% ± 1.4%) the
fulani group (9.9% ± 2.5%; p = .0003). study provides example host
genetic variation may influence selection dynamics pathogen's drug
resistance.

doi: 10.1093/infdis/jir629 
pmid: 21998472  [indexed medline]

